Drug eluting stents (DES) is expected to rise at annual rate of 5.35% in forecast period of 2020 to 2027 and is anticipated to reach USD 9.20 billion by 2027 due to the risk associated with thrombosis and disruption and the lack of skilled professionals will act as a restrain to the growth of the market.
Asia-Pacific is expected to be the largest growing region because of improvement in healthcare infrastructure and increasing healthcare spending.
Drug Eluting Stents (DES) Market Scenario
According to Data Bridge Market Research the market for drug eluting stents (DES) is raising due to increasing cases of cardiovascular diseases, raising popularity of minimally invasive endovascular surgeries and the increasing demand of DES for the treatment of atherosclerosis. Moreover, with the increasing cases of arterial diseases will create new and ample opportunity for the market to grow.
Now the question is which are the other regions intuitive is targeting? Data Bridge Market Research has forecasted North America to dominate the drug eluting stents (DES) market due to favorable reimbursement policies and strict rules & norms for medical device manufacturing.
For more analysis on the drug eluting stents (DES) market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-drug-eluting-stents-des-market
Drug Eluting Stents (DES) Market Scope
Drug eluting stents (DES) market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America.
- All country based analysis of drug eluting stents (DES) market is further analyzed based on maximum granularity into further segmentation. On the basis of coating, the drug eluting stents (DES) market is segmented into polymer based coating, biodegradable, non-biodegradable, polymer free coating, microporous surface, microstructured surface, slotted tubular surface and nanoporous surface. Based on end- users, the drug eluting stents (DES) market is segmented into hospitals, cardiology centers and ambulatory surgical centers. The application segment of the drug eluting stents (DES) market is divided into coronary artery disease and peripheral artery disease. On the basis of drugs, the drug eluting stents (DES) market is segmented into sirolimus, pactitaxel, zotarolimus, everolimus, biolimus and others. Based on generation, the drug eluting stents (DES) market is segmented into 1st Generation, 2nd Generation, 3RD Generation, and 4TH Generation.
- Drug-eluting stent is a stent that is inserted in narrowed peripheral or coronary arteries that slowly raise a drug to inhibit the replication of cells. They are more chosen than bare metal stents to avoid the blockage from repeating.
To know more about the study, https://www.databridgemarketresearch.com/reports/global-drug-eluting-stents-des-market
Key Pointers Covered in the Drug Eluting Stents (DES) Market Industry Trends and Forecast to 2027
- Market Size
- Market New Sales Volumes
- Market Replacement Sales Volumes
- Market Installed Base
- Market By Brands
- Market Procedure Volumes
- Market Product Price Analysis
- Market Healthcare Outcomes
- Market Cost of Care Analysis
- Market Regulatory Framework and Changes
- Market Prices and Reimbursement Analysis
- Market Shares in Different Regions
- Recent Developments for Market Competitors
- Market Upcoming Applications
- Market Innovators Study
Key Market Competitors Covered in the Report
- Abbott
- B. Braun Melsungen AG
- Biosensors International Group, Ltd
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic
- MicroPort Scientific Corporation
- ORBUSNEICH MEDICAL
- Relisys Medical Devices Limited
- REVA Medical Inc
- Sino Medical Sciences Technology Inc
- STENTYS SA
- lepumedical.com
- Cook
- HEXACATH
- Cardinal Health
Above are the key players covered in the report, to know about more and exhaustive list of drug eluting stents (DES) companies’ contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-drug-eluting-stents-des-market
Research Methodology of Drug Eluting Stents (DES) Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Related Reports
- Europe Ophthalmology Drugs and Devices Market – Industry Trends and Forecast to 2027
- Global Migraine Drugs Market– Industry Trends and Forecast to 2025
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
